EN
Newsroom
The Latest
Press releases
argenx Stories
Newsroom
The Latest
Press releases
argenx Stories
A
A
Home
Contact us
Home
Patients
Our commitment
Disease areas
Patient Access
Untold Stories
Pipeline
Our pipeline
Partnered programs
Externally Sponsored Research
Publications
Innovation
IIP
Clinical Trials
Antibody engineering
Co-creation in Action
Partner with Us
Academic collaborators
Products
Investors
Stock information
Events & Presentations
Financial reports
Shareholder meetings
Corporate governance
Environmental, Social and Governance
AFM filings
SEC filings
Analyst coverage
Careers
About
One Team
Cultural Pillars
Management Team
Board of Directors
Grants
Ethics and Responsibility
Contact us
Global websites
Global:
English
Local websites
Canada:
English
Français
France:
Français
Germany:
Deutsch
Japan:
日本語
Netherlands:
Nederlands
Spain:
Español
United Kingdom:
English
Italy
Italian
Home
Patients
Our commitment
Disease areas
Patient Access
Untold Stories
Pipeline
Our pipeline
Partnered programs
Externally Sponsored Research
Publications
Innovation
IIP
Clinical Trials
Antibody engineering
Co-creation in Action
Partner with Us
Academic collaborators
Products
Investors
Stock information
Events & Presentations
Financial reports
Shareholder meetings
Corporate governance
Environmental, Social and Governance
AFM filings
SEC filings
Analyst coverage
Careers
Newsroom
The Latest
argenx stories
Press releases
About
One Team
Cultural Pillars
Management Team
Board of Directors
Grants
Ethics and Responsibility
Contact us
Home
Patients
Multifocal Motor Neuropathy (MMN)
Severe Autoimmunity
X
Facebook
LinkedIn
WhatsApp
